Clinical Trials Browser

OTHER_GOV × HER2 Positive Breast Cancer × Clear all

NCT03735966 2022-12-01

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.

Phase 2 Completed

HER2 Positive Breast Cancer

NCT03947242 2019-05-15

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer.

Phase NA Unknown

HER2 Positive Breast Cancer